Beyond HER2 expression in breast cancer: Investigating alternative splicing profiles as a mechanism of resistance to anti-HER2 therapies

Gabriela D. A. Guardia, Carlos H dos Anjos, Aline Rangel-Pozzo, Filipe F. dos Santos, Alexander Birbrair, Paula F. Asprino, Anamaria A. Camargo, Pedro A F Galante
doi: https://doi.org/10.1101/2024.11.25.24317569

Data Availability

All data produced in the present study are available in the manuscript or can be requested to the authors

Back to top
Posted November 26, 2024.
Download PDF
Data/Code
Email
Beyond HER2 expression in breast cancer: Investigating alternative splicing profiles as a mechanism of resistance to anti-HER2 therapies
Gabriela D. A. Guardia, Carlos H dos Anjos, Aline Rangel-Pozzo, Filipe F. dos Santos, Alexander Birbrair, Paula F. Asprino, Anamaria A. Camargo, Pedro A F Galante
medRxiv 2024.11.25.24317569; doi: https://doi.org/10.1101/2024.11.25.24317569
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area